Page last updated: 2024-08-16

sulfinpyrazone and practolol

sulfinpyrazone has been researched along with practolol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Schröder, R1
Smith, JW1
Pentecost, BL1
Lown, B; Raeder, EA; Verrier, RL1

Reviews

1 review(s) available for sulfinpyrazone and practolol

ArticleYear
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
    Deutsche medizinische Wochenschrift (1946), 1981, Apr-24, Volume: 106, Issue:17

    Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors

1981

Trials

1 trial(s) available for sulfinpyrazone and practolol

ArticleYear
Preventing the second infarct.
    Journal of the Royal College of Physicians of London, 1980, Volume: 14, Issue:1

    Topics: Adult; Animals; Clinical Trials as Topic; Death, Sudden; Dogs; Electrocardiography; Exercise Therapy; Humans; Hyaluronoglucosaminidase; Middle Aged; Monitoring, Physiologic; Myocardial Infarction; Practolol; Recurrence; Smoking Prevention; Sulfinpyrazone

1980

Other Studies

4 other study(ies) available for sulfinpyrazone and practolol

ArticleYear
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Mortality after recovery from myocardial infarction.
    Journal of chronic diseases, 1980, Volume: 33, Issue:1

    Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Death, Sudden; Heart Failure; Humans; Myocardial Infarction; Practolol; Risk; Sulfinpyrazone; Time Factors

1980
Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart.
    The American journal of cardiology, 1982, Volume: 50, Issue:2

    Topics: Animals; Coronary Disease; Dogs; Female; Heart; Heart Conduction System; Lidocaine; Male; Myocardial Contraction; Norepinephrine; Practolol; Refractory Period, Electrophysiological; Sulfinpyrazone; Ventricular Fibrillation

1982